Moteur de recherche d’entreprises européennes

Financement de l’UE (10 000 000 €) : ERA-NET pour l’établissement de synergies entre la programmation conjointe sur la recherche sur les maladies neurodégénératives et Horizon 2020 Hor 01/01/2015 Programme de recherche et d'innovation de l'UE « Horizon »

Vue d’ensemble

Texte

ERA-NET pour l’établissement de synergies entre la programmation conjointe sur la recherche sur les maladies neurodégénératives et Horizon 2020

Over 12 million people in Europe suffer from neurodegenerative diseases (ND), yet treatments that prevent or stop the progression of neurodegeneration are still lacking. Tackling this grand challenge requires enhanced coordination of national efforts to accelerate discovery. Such synergies have been created among 28 countries in the pilot EU JPI on Neurodegenerative Disease Research (JPND). JPND has a long standing experience in collaborative action with €75 million of additional national funds being successfully mobilized between 2011 and 2014 to support transnational research programs. The JPND Research Strategy is now ripe for further enhancement in tight coordination with the EC through an ERA-Net Cofund instrument JPco-fuND with an unprecedented commitment of €30 million of national funds associated to a highly incentivizing EC top-up fund. Among the most burning questions, three priority topics have emerged through a consultative process between researchers and JPND members in order to unlock several major issues within ND research: the identification of genetic, epigenetic and environmental risk and protective factors, the development and maintenance of longitudinal cohorts, the creation of advanced experimental models. These are key questions of equal priority to increase understanding of ND mechanisms that will be addressed through a common joint transnational call allowing a significant acceleration of the execution of the JPND research strategy. Moreover, to expand the impact of JPco-fuND, JPND will continue to implement other actions without EU co-funding such as aligning national research strategies, making databases more accessible and interoperable, developing enabling capacities such as supportive infrastructure and platforms, capacity building, education and training. These actions are required in parallel to achieve the highest impact for the patients, their carers and for society as whole and address this grand challenge in the coming years.


Agence Nationale de la Recherche 647 734 €
Bundesministerium FUR Bildung 175 499 €
Bundesministerium FUR Wirtschaft, Energie UND Tourismus 0,00 €
Canadian Institutes OF Health Research 0,00 €
Deutsches Zentrum FUR Luft - UND Raumfahrt e. V. 1 814 802 €
Fondation de Cooperation Scientifique Maladie d'Alzheimer et Maladies Apparentees 59 813 €
Fonds de la Recherche Scientifique- FNRS 118 312 €
Fonds National de la Recherche 206 062 €
Fonds Voor Wetenschappelijk Onderzoek-Vlaanderen 118 312 €
Forskingsradet FOR Halsa Arbetslivoch Valfard 59 813 €
Fundacao para A Ciencia e A Tecnologia 323 061 €
Innovationsfonden 352 311 €
Institut National de la Sante et de la Recherche Medicale 59 813 €
Instituto de Salud Carlos III 157 799 €
Ministero Dell'Istruzione, Dell'Universita' E Della Ricerca 59 813 €
Ministero Dell'Universita E Della Ricerca 438 747 €
Ministero Della Salute 498 560 €
Ministerstvo Skolstva Vyskumu Vyvoja A Mladeze sr 352 311 €
Ministerul Educatiei si Cercetarii 147 562 €
Ministry OF Health 130 012 €
Narodowe Centrum Badan i Rozwoju 176 812 €
Norges Forskningsrad 498 560 €
Suomen Akatemia 352 311 €
Turkiye Bilimsel VE Teknolojik Arastirma Kurumu 293 811 €
United Kingdom Research and Innovation 791 058 €
Vetenskapsradet - Swedish Research Council 1 229 806 €
Zorgonderzoek Nederland ZON 937 307 €

https://cordis.europa.eu/project/id/643417

Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.